AboutContactTerms & Privacy
© 2026 Coverager
All Rights Reserved

Enobia Pharma

Enobia Pharma develops therapies for the treatment of serious genetic bone disorders.

Headquarters
Montréal, Quebec, Canada
Founded
1997
Operating Status
Acquired
Ownership Type
Links
Number of funding rounds 5
Number of investors 8
Total funding amount $158.35M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.